Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126516) titled 'Study on the Mechanism of SIRT5-SREBF1-SCD1 Axis in Regulating Lipid Synthesis and Malignant Progression in Renal Clear Cell Carcinoma' on June 10.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Henan Provincial People's Hospita
Condition:
Clear Cell Renal Cell Carcinoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-10
Target Sample Size: Renal Clear Cell Carcinoma (ccRCC) Clinical Cohort:450;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=327568
Published by HT Digital Content Service...